Jürgens, 1962 - Google Patents
The significance of the Hageman-factor for the effect of wettable surface on thrombocytesJürgens, 1962
- Document ID
- 6555915753772084724
- Author
- Jürgens J
- Publication year
- Publication venue
- Thrombosis and Haemostasis
External Links
Snippet
1. Disintegration of thrombocytes through contact with wettable surfaces—precipitated in the glass rotator in the form of platelet agglomeration—demands the presence of the Hageman- factor, prothrombin and the fibrinogen on the surface of the thrombocytes. 2. For the …
- 210000001772 Blood Platelets 0 title abstract description 145
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/16—Blood plasma; Blood serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Margolis | Initiation of blood coagulation by glass and related surfaces | |
| Teitel et al. | Protection of factor Xa from neutralization by the heparin-antithrombin complex. | |
| Ratnoff et al. | A familial hemorrhagic trait associated with a deficiency of a clot-promoting fraction of plasma | |
| Tocantins et al. | The clot accelerating effect of dilution on blood and plasma. Relation to the mechanism of coagulation of normal and hemophilic blood | |
| Nilsson et al. | Intrauterine death and circulating anticoagulant (“antithromboplastin”) | |
| Deutsch et al. | Differentiation of certain platelet factors related to blood coagulation | |
| Biggs et al. | The action of thromboplastic substances | |
| Stefanini | Mechanism of blood coagulation in normal and pathologic conditions | |
| Conley et al. | The clotting behavior of human “platelet-free” plasma: evidence for the existence of a “plasma thromboplastin” | |
| Hellem et al. | Investigations on adenosine diphosphate (ADP) induced platelet adhesiveness in vitro | |
| Kwaan | Disseminated intravascular coagulation | |
| Biggs et al. | The reaction of haemophilic plasma to thromboplastin | |
| Quick et al. | Fibrin, a factor influencing the consumption of prothrombin in coagulation | |
| McClaughry et al. | Prothrombin, thromboplastin, Ac-globulin and platelet accelerator: quantitative interrelationships | |
| Chan et al. | A study of the coagulant properties of Malayan pit‐viper venom | |
| Singer et al. | Circulating anticoagulants in hemophilia and in hemophilia-like disease | |
| Jürgens | The significance of the Hageman-factor for the effect of wettable surface on thrombocytes | |
| Surgenor et al. | A system for the separation of the protein components of human plasma. II. The components of the clotting process. | |
| Jacox | Studies on the activation of a serum “prothrombin-converting factor” | |
| Stefanini | Basic mechanisms of hemostasis | |
| Haanen et al. | A case of Hageman-factor deficiency and a method to purify the factor | |
| Tocantins | Relation of contacting surface and anticephalin activity to the maintenance of the fluidity and coagulability of blood | |
| Johnson et al. | A new approach to the thrombocytopathies. Thrombocytopathy A | |
| Munro | Properties of an anticoagulant found in the blood of a hemophiliac | |
| GIERCKSKY et al. | The effect of intravenous injection of purified human tissue thromboplastin in rats |